Skip to content

QuidelOrtho Corporation QDEL Cash Provided by (Used in) Investing Activity, Including Discontinued Operation

Cash Provided by (Used in) Investing Activity, Including Discontinued Operation at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
-$407.85M-797%
CareDx logo
CareDxCDNA
$11.06M+735%
Haemonetics logo
HaemoneticsHAE
-$86.61M
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Revvity logo
RevvityRVTY
Zoetis logo
ZoetisZTS

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$832.61M-56.1%
Enterprise value$3.8B-22.0%
P/S0.3×-0.4×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's cash provided by (used in) investing activity, including discontinued operation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's cash provided by (used in) investing activity, including discontinued operation?
QuidelOrtho Corporation (QDEL) reported cash provided by (used in) investing activity, including discontinued operation of -$34M in Q1 2026.
How has QuidelOrtho Corporation's cash provided by (used in) investing activity, including discontinued operation changed year-over-year?
QuidelOrtho Corporation's cash provided by (used in) investing activity, including discontinued operation increased by 39.5% year-over-year, from -$56.2M to -$34M.
What is the long-term trend for QuidelOrtho Corporation's cash provided by (used in) investing activity, including discontinued operation?
Over 3 years (2022 to 2025), QuidelOrtho Corporation's cash provided by (used in) investing activity, including discontinued operation has grown at a -51.1% compound annual growth rate (CAGR), from -$1.64B to -$192.7M.
What does cash provided by (used in) investing activity, including discontinued operation mean?
The total net cash flow resulting from all investing activities, including capital expenditures, acquisitions, and the purchase or sale of securities. It serves as a primary indicator of how much capital the company is reinvesting into its long-term growth and asset base.